Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
BioAge Labs Inc. (BIOA)
USD23.05
+0.27 (+1.19%)
US NASDAQ Healthcare Biotechnology
Address
5885 Hollis Street 94608
Emeryville, CA, US
Emeryville, CA, US
CEO
Kristen Fortney
Website
bioagelabs.com
IPO
2024-09-26
CIK 1709941 ISIN US09077V1008
Description
BioAge Labs, Inc., a clinical-stage biopharmaceutical company, develops therapeutic product candidates for metabolic diseases. The company’s technology platform and differentiated human datasets that allows users to identify targets based on insights into molecular changes that drive aging. Its lead product candidate includes BGE-102, an orally available brain-penetrant small-molecule NLRP3 inhibitor which is in Phase 1 clinical trail for the treatment of atherosclerotic cardiovascular disease, as well as for the treatment of diabetic macular edema and geographic atrophy; and develops APJ agonists for obesity, including programs targeting both oral and parenteral administration. The company has collaboration agreement with Novartis Pharma AG to identify and validate novel therapeutic drug targets by investigating the biological mechanisms that drive diseases related to aging and mediate. BioAge Labs, Inc. was incorporated in 2015 and is headquartered in Emeryville, California.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD23.05
+0.27 (+1.19%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
489.7K
Beta
0.62
Float Shares
22.82M
Free Float %
63.4%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.94% | -1.09% | +12.17% | -8.93% | +126.72% | +37.26% | +346.19% | -0.82% | -0.82% | -0.82% | -0.82% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (3 ratings, all time)
Buy
Price Targets & DCF
Current price
23.05
Low
23.00
-0.2%
Consensus
45.00
+95.2%
Median
50.00
+116.9%
High
62.00
+169.0%
DCF (Unlevered)
9.15
-60.3%
DCF (Levered)
6.76
-70.7%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
71% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 3 | 0 |
| Hold | 2 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | 2 |
56.00
+143.0%
|
| Last Year | 4 |
36.75
+59.4%
|
| All Time | 9 |
31.78
+37.9%
|
Quality scores
Altman Z-Score
20.09
Safe zone
Piotroski F-Score
3 / 9
Average
MOAT Score
1 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
3 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%— Q1'26: +91.0% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%+66.2% ★ Q1'26: -44.4% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-1,027.6% Q1'26: -868.4% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%-888.4% Q1'26: -915.4% (vs Q1'25)
-
ROIC Biotechnology: -16.1%— Q1'26: +260,256.4% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+235.0% Q1'26: +18.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.07× Q1'26: -0.04× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 4 Rev. Ana. 4 EPS Ana. |
Dec 2027 5 Rev. Ana. 5 EPS Ana. |
Dec 2028 5 Rev. Ana. 6 EPS Ana. |
Dec 2029 2 Rev. Ana. 4 EPS Ana. |
Dec 2030 2 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
—
est: 1.45M (-100.0%)
|
9.00M
est: 7.11M (+26.5%)
|
5.34M
704.3K – 15.64M
-24.9% YoY
|
19.10M
950.1K – 37.26M
+257.8% YoY
|
2.43M
320.4K – 7.11M
-87.3% YoY
|
4.35M
573.7K – 12.74M
+79.1% YoY
|
4.69M
618.4K – 13.73M
+7.8% YoY
|
| EBITDA |
-68.58M
est: 725.5K (-9,552.1%)
|
-79.70M
est: 3.56M (-2,341.1%)
|
2.67M
352.2K – 7.82M
-24.9% YoY
|
9.55M
475.1K – 18.63M
+257.8% YoY
|
1.21M
160.2K – 3.56M
-87.3% YoY
|
2.17M
286.9K – 6.37M
+79.1% YoY
|
2.34M
309.2K – 6.87M
+7.8% YoY
|
| EBIT |
-68.74M
est: 725.5K (-9,575.1%)
|
-79.91M
est: 3.56M (-2,347.1%)
|
2.67M
352.2K – 7.82M
-24.9% YoY
|
9.55M
475.1K – 18.63M
+257.8% YoY
|
1.21M
160.2K – 3.56M
-87.3% YoY
|
2.17M
286.9K – 6.37M
+79.1% YoY
|
2.34M
309.2K – 6.87M
+7.8% YoY
|
| Net Income |
-71.11M
est: -130.48M (+45.5%)
|
-80.61M
est: -89.93M (+10.4%)
|
-96.42M
-109.95M – -82.90M
-7.2% YoY
|
-77.90M
-99.94M – -55.86M
+19.2% YoY
|
-113.71M
-133.80M – -93.62M
-46.0% YoY
|
-122.01M
-428.04M – 15.68M
-7.3% YoY
|
-140.69M
-493.55M – 18.08M
-15.3% YoY
|
| SGA |
19.16M
est: 2.21M (+767.0%)
|
27.81M
est: 10.83M (+156.8%)
|
8.13M
1.07M – 23.82M
-24.9% YoY
|
29.09M
1.45M – 56.74M
+257.8% YoY
|
3.70M
487.9K – 10.83M
-87.3% YoY
|
6.62M
873.8K – 19.40M
+79.1% YoY
|
7.14M
941.8K – 20.91M
+7.8% YoY
|
| EPS |
-6.63
est: -3.64 (-82.3%)
|
-2.24
est: -2.27 (+1.2%)
|
-2.64
-3.06 – -2.31
-16.4% YoY
|
-2.34
-2.78 – -1.55
+11.3% YoY
|
-3.00
-3.72 – -2.61
-28.2% YoY
|
-3.40
-11.91 – 0.44
-13.1% YoY
|
-3.92
-13.74 – 0.50
-15.3% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-07 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-06 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-05 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-04 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-05-01 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-30 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-29 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-28 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-27 | C+ | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 3/5 |
| 2026-04-24 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-23 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-22 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-21 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-20 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-17 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
| 2026-04-16 | C | 2/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-23.27M
OE per share TTM
-0.55
Owner's Yield
-3.05%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
60.4%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
26
Total invested
11.16M
Insider transactions (90d)
1
Beneficial owners (>5%)
26
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Benjamin Horowitz | 3.23M | 9.00% | — | 3.23M | — | 10.00 | IN | United States | 2024-10-04 | ↗ |
| 2 | Marc Andreessen | 3.23M | 9.00% | — | 3.23M | — | 10.00 | IN | United States | 2024-10-04 | ↗ |
| 3 | Kristen Fortney | 2.33M | 6.60% | 2.30M | — | 2.30M | 31.3K | IN | United States of America | 2024-11-12 | ↗ |
| 4 | Dr. James I. Healy (“Healy”) | 2.30M | 6.70% | — | 2.30M | — | 2.30M | IN | U.S. Citizen | 2024-09-30 | ↗ |
| 5 | Dr. Maha Katabi (“Katabi”) | 2.23M | 6.50% | — | 2.23M | — | 2.23M | IN | Canadian Citizen | 2024-09-30 | ↗ |
| 6 | Sofinnova Management XI, L.L.C. (“SM XI LLC”) | 2.23M | 6.50% | 2.23M | — | 2.23M | 10.00 | OO | Delaware | 2024-09-30 | ↗ |
| 7 | Sofinnova Management XI, L.P. (“SM XI LP”) | 2.23M | 6.50% | 2.23M | — | 2.23M | 10.00 | PN | Delaware | 2024-09-30 | ↗ |
| 8 | Sofinnova Venture Partners XI, L.P. (“SVP XI”) | 2.23M | 6.50% | 2.23M | — | 2.23M | 10.00 | PN | Delaware | 2024-09-30 | ↗ |
| 9 | Peter Kolchinsky | 2.21M | 6.20% | — | 2.21M | — | 2.21M | HC, IN | Delaware | 2024-10-07 | ↗ |
| 10 | RA Capital Management, L.P. | 2.21M | 6.20% | — | 2.21M | — | 2.21M | IA, PN | Delaware | 2024-10-07 | ↗ |
| 11 | Rajeev Shah | 2.21M | 6.20% | — | 2.21M | — | 2.21M | HC, IN | Delaware | 2024-10-07 | ↗ |
| 12 | RA Capital Healthcare Fund, L.P. | 1.81M | 5.10% | — | 1.81M | — | 1.81M | PN | Delaware | 2024-10-07 | ↗ |
| 13 | VK Services, LLC | 1.80M | 5.00% | — | 1.80M | — | 1.80M | OO | Delaware, United States of America | 2024-11-14 | ↗ |
| 14 | Vinod Khosla | 1.80M | 5.00% | — | 1.80M | — | 1.80M | IN | Delaware, United States of America | 2024-11-14 | ↗ |
| 15 | Khosla Ventures Opportunity Associates I, LLC | 1.36M | 3.80% | — | 1.36M | — | 1.36M | OO | Delaware, United States of America | 2024-11-14 | ↗ |
| 16 | Khosla Ventures Opportunity I, LP | 1.36M | 3.80% | — | 1.36M | — | 1.36M | PN | Delaware, United States of America | 2024-11-14 | ↗ |
| 17 | AH Bio Fund I, L.P. | 1.27M | 3.50% | 1.27M | 1.27M | 1.27M | 10.00 | PN | Delaware | 2024-10-04 | ↗ |
| 18 | AH Equity Partners Bio I, L.L.C. | 1.27M | 3.50% | 1.27M | 1.27M | 1.27M | 10.00 | OO | Delaware | 2024-10-04 | ↗ |
| 19 | AH Equity Partners LSV III, L.L.C. | 1.12M | 3.10% | 1.12M | 1.12M | 1.12M | 10.00 | OO | Delaware | 2024-10-04 | ↗ |
| 20 | Andreessen Horowitz LSV Fund III, L.P. | 1.12M | 3.10% | 1.12M | 1.12M | 1.12M | 10.00 | PN | Delaware | 2024-10-04 | ↗ |
| 21 | AH Bio Fund IV, L.P. | 655.3K | 1.80% | 655.3K | 655.3K | 655.3K | 10.00 | PN | Delaware | 2024-10-04 | ↗ |
| 22 | AH Equity Partners Bio IV, L.L.C. | 655.3K | 1.80% | 655.3K | 655.3K | 655.3K | 10.00 | OO | Delaware | 2024-10-04 | ↗ |
| 23 | Khosla Ventures Associates VI, LLC | 437.2K | 1.20% | — | 437.2K | — | 437.2K | OO | Delaware, United States of America | 2024-11-14 | ↗ |
| 24 | Khosla Ventures VI, LP | 437.2K | 1.20% | — | 437.2K | — | 437.2K | PN | Delaware, United States of America | 2024-11-14 | ↗ |
| 25 | AH Bio Fund III, L.P. | 189.6K | 0.50% | 189.6K | 189.6K | 189.6K | 10.00 | PN | Delaware | 2024-10-04 | ↗ |
| 26 | AH Equity Partners Bio III, L.L.C. | 189.6K | 0.50% | 189.6K | 189.6K | 189.6K | 10.00 | OO | Delaware | 2024-10-04 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
26
-88 vs prev Q
New positions
6
Closed positions
93
Increased
16
Reduced
3
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | NANO CAP NEW MILLENNIUM GROWTH FUND L P | 80.0K +80.0K (+100.0%) | 1.06B +1.1B (+100.0%) | 0.22% +0.223 pp | 0.90% +0.903 pp | USD13.23 +0.0% | 1 qtrs NEW |
| 2 | AH CAPITAL MANAGEMENT, L.L.C. | 3.23M +— (+0.0%) | 44.07M +25.1M (+131.8%) | 9.02% +0.000 pp | 2.79% +1.427 pp | USD19.78 -33.1% | 6 qtrs — |
| 3 | SOFINNOVA INVESTMENTS, INC. | 2.29M +— (+0.0%) | 30.35M +16.9M (+125.0%) | 6.40% +0.000 pp | 1.31% +0.571 pp | USD20.80 -36.4% | 6 qtrs — |
| 4 | CORMORANT ASSET MANAGEMENT, LP | 2.04M -100.0K (-4.7%) | 27.00M +14.4M (+114.5%) | 5.69% -0.279 pp | 1.25% +0.380 pp | USD15.09 -12.3% | 6 qtrs — |
| 5 | OCTAGON CAPITAL ADVISORS LP | 1.60M +1.6M (+100.0%) | 21.14M +21.1M (+100.0%) | 4.46% +4.458 pp | 2.57% +2.567 pp | USD13.23 +0.0% | 1 qtrs NEW |
| 6 | BLACKROCK, INC. | 1.53M +247.9K (+19.4%) | 20.21M +12.7M (+168.6%) | 4.26% +0.692 pp | 0.00% +0.000 pp | USD6.38 +107.4% | 5 qtrs — |
| 7 | VANGUARD GROUP INC | 1.41M -236.5K (-14.3%) | 18.72M +9.0M (+92.8%) | 3.95% -0.660 pp | 0.00% +0.000 pp | USD4.88 +171.1% | 6 qtrs — |
| 8 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.05M +1.1M (+100.0%) | 13.89M +13.9M (+100.0%) | 2.93% +2.929 pp | 0.02% +0.021 pp | USD13.23 +0.0% | 1 qtrs NEW |
| 9 | ORBIMED ADVISORS LLC | 790.9K +— (+0.0%) | 10.46M +5.8M (+125.0%) | 2.21% +0.000 pp | 0.21% +0.105 pp | USD20.80 -36.4% | 6 qtrs — |
| 10 | SANDS CAPITAL VENTURES, LLC | 786.4K +— (+0.0%) | 10.40M +5.8M (+125.0%) | 2.19% +0.000 pp | 2.01% +0.994 pp | USD20.80 -36.4% | 6 qtrs — |
| 11 | PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 653.4K +— (+0.0%) | 8.64M +4.8M (+125.0%) | 1.82% +0.000 pp | 3.34% +1.121 pp | USD17.91 -26.1% | 6 qtrs — |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | 591.4K +28.6K (+5.1%) | 7.83M +4.5M (+136.4%) | 1.65% +0.080 pp | 0.00% +0.000 pp | USD5.60 +136.3% | 5 qtrs — |
| 13 | STATE STREET CORP | 422.8K +224.7K (+113.4%) | 5.59M +4.4M (+380.2%) | 1.18% +0.627 pp | 0.00% +0.000 pp | USD9.26 +42.9% | 5 qtrs — |
| 14 | JANUS HENDERSON GROUP PLC | 409.2K +409.2K (+100.0%) | 5.41M +5.4M (+100.0%) | 1.14% +1.141 pp | 0.00% +0.002 pp | USD13.23 +0.0% | 1 qtrs NEW |
| 15 | REDPOINT MANAGEMENT, LLC | 383.3K +— (+0.0%) | 5.07M +2.8M (+125.0%) | 1.07% +0.000 pp | 3.73% +2.371 pp | USD20.80 -36.4% | 6 qtrs — |
| 16 | D. E. SHAW & CO., INC. | 339.9K +235.6K (+226.0%) | 4.50M +3.9M (+633.4%) | 0.95% +0.657 pp | 0.00% +0.002 pp | USD10.63 +24.5% | 3 qtrs — |
| 17 | JACOBS LEVY EQUITY MANAGEMENT, INC | 334.1K +121.0K (+56.8%) | 4.42M +3.2M (+252.8%) | 0.93% +0.338 pp | 0.02% +0.012 pp | USD7.43 +78.1% | 3 qtrs — |
| 18 | MORGAN STANLEY | 311.7K +83.5K (+36.6%) | 4.12M +2.8M (+207.3%) | 0.87% +0.233 pp | 0.00% +0.000 pp | USD6.82 +94.0% | 6 qtrs — |
| 19 | ACADIAN ASSET MANAGEMENT LLC | 278.0K +267.3K (+2,503.6%) | 3.67M +3.6M (+5,919.7%) | 0.78% +0.746 pp | 0.01% +0.006 pp | USD12.93 +2.3% | 3 qtrs — |
| 20 | COMPREHENSIVE FINANCIAL MANAGEMENT LLC | 271.8K +— (+0.0%) | 3.60M +2.0M (+125.0%) | 0.76% +0.000 pp | 0.11% +0.064 pp | USD20.80 -36.4% | 6 qtrs — |
| 21 | DIADEMA PARTNERS LP | 271.2K +271.2K (+100.0%) | 3.59M +3.6M (+100.0%) | 0.76% +0.756 pp | 0.62% +0.618 pp | USD13.23 +0.0% | 1 qtrs NEW |
| 22 | SPHERA FUNDS MANAGEMENT LTD. | 243.0K +243.0K (+100.0%) | 3.22M +3.2M (+100.0%) | 0.68% +0.678 pp | 0.62% +0.622 pp | USD13.23 +0.0% | 1 qtrs NEW |
| 23 | CITADEL ADVISORS LLC | 230.5K +116.5K (+102.1%) | 3.05M +2.4M (+354.8%) | 0.64% +0.325 pp | 0.00% +0.000 pp | USD8.76 +51.0% | 3 qtrs — |
| 24 | INVESCO LTD. | 228.7K +228.7K (+100.0%) | 3.03M +3.0M (+100.0%) | 0.64% +0.638 pp | 0.00% +0.001 pp | USD13.23 +0.0% | 1 qtrs NEW |
| 25 | MILLENNIUM MANAGEMENT LLC | 228.4K -78.1K (-25.5%) | 3.02M +1.2M (+67.6%) | 0.64% -0.218 pp | 0.00% +0.001 pp | USD5.67 +133.3% | 6 qtrs — |
| 26 | MARSHALL WACE, LLP | 222.9K +48.8K (+28.0%) | 2.95M +1.9M (+188.0%) | 0.62% +0.136 pp | 0.00% +0.002 pp | USD6.05 +118.7% | 6 qtrs — |
| 27 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 219.8K +28.5K (+14.9%) | 2.91M +1.8M (+158.5%) | 0.61% +0.079 pp | 0.00% +0.000 pp | USD6.51 +103.2% | 5 qtrs — |
| 28 | ALGERT GLOBAL LLC | 196.0K +184.9K (+1,658.0%) | 2.59M +2.5M (+3,830.3%) | 0.55% +0.516 pp | 0.04% +0.039 pp | USD12.71 +4.1% | 3 qtrs — |
| 29 | BANK OF AMERICA CORP /DE/ | 188.7K +177.6K (+1,596.9%) | 2.50M +2.4M (+3,718.1%) | 0.53% +0.495 pp | 0.00% +0.000 pp | USD12.79 +3.4% | 6 qtrs — |
| 30 | NORTHERN TRUST CORP | 167.5K -19.1K (-10.2%) | 2.22M +1.1M (+101.9%) | 0.47% -0.053 pp | 0.00% +0.000 pp | USD5.22 +153.4% | 5 qtrs — |
| 31 | ADAR1 CAPITAL MANAGEMENT, LLC | 135.6K -1.7M (-92.8%) | 1.79M -9.3M (-83.8%) | 0.38% -4.866 pp | 0.13% -0.907 pp | USD4.07 +225.1% | 5 qtrs — |
| 32 | WALLEYE CAPITAL LLC | 134.8K +121.9K (+945.5%) | 1.78M +1.7M (+2,252.3%) | 0.38% +0.340 pp | 0.01% +0.005 pp | USD12.36 +7.0% | 3 qtrs — |
| 33 | GOLDMAN SACHS GROUP INC | 126.2K +36.6K (+40.8%) | 1.67M +1.1M (+216.7%) | 0.35% +0.102 pp | 0.00% +0.000 pp | USD9.62 +37.5% | 6 qtrs — |
| 34 | FMR LLC | 117.7K +26.6K (+29.2%) | 1.56M +1.0M (+190.6%) | 0.33% +0.074 pp | 0.00% +0.000 pp | USD6.16 +114.8% | 5 qtrs — |
| 35 | BNP PARIBAS ARBITRAGE, SNC | 111.8K +86.1K (+334.4%) | 1.48M +1.3M (+877.4%) | 0.31% +0.240 pp | 0.00% +0.001 pp | USD11.50 +15.0% | 5 qtrs — |
| 36 | AMERIPRISE FINANCIAL INC | 83.0K +52.5K (+172.3%) | 1.10M +918.5K (+512.8%) | 0.23% +0.146 pp | 0.00% +0.000 pp | USD9.89 +33.8% | 3 qtrs — |
| 37 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 77.6K +25.0K (+47.5%) | 1.03M +717.4K (+231.9%) | 0.22% +0.070 pp | 0.02% +0.015 pp | USD7.06 +87.4% | 3 qtrs — |
| 38 | PERSISTENT ASSET PARTNERS LTD | 72.8K +72.8K (+100.0%) | 962.8K +962.8K (+100.0%) | 0.20% +0.203 pp | 0.43% +0.432 pp | USD13.23 +0.0% | 1 qtrs NEW |
| 39 | BANK OF NEW YORK MELLON CORP | 61.6K +3.6K (+6.1%) | 814.4K +473.4K (+138.8%) | 0.17% +0.010 pp | 0.00% +0.000 pp | USD5.13 +157.9% | 5 qtrs — |
| 40 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 52.4K +42.3K (+418.6%) | 693.8K +634.3K (+1,066.8%) | 0.15% +0.118 pp | 0.00% +0.000 pp | USD11.43 +15.7% | 4 qtrs — |
| 41 | AQR CAPITAL MANAGEMENT LLC | 51.9K +16.2K (+45.2%) | 686.9K +476.7K (+226.8%) | 0.14% +0.045 pp | 0.00% +0.000 pp | USD7.11 +86.1% | 3 qtrs — |
| 42 | SCHONFELD STRATEGIC ADVISORS LLC | 51.4K +51.4K (+100.0%) | 679.6K +679.6K (+100.0%) | 0.14% +0.143 pp | 0.00% +0.003 pp | USD13.23 +0.0% | 1 qtrs NEW |
| 43 | SQUAREPOINT OPS LLC | 51.3K +51.3K (+100.0%) | 678.3K +678.3K (+100.0%) | 0.14% +0.143 pp | 0.00% +0.001 pp | USD13.23 +0.0% | 1 qtrs NEW |
| 44 | STONEPINE CAPITAL MANAGEMENT, LLC | 45.0K -143.6K (-76.1%) | 595.4K -513.4K (-46.3%) | 0.13% -0.401 pp | 0.43% -0.467 pp | USD4.38 +202.1% | 4 qtrs — |
| 45 | JUMP FINANCIAL, LLC | 42.8K +42.8K (+100.0%) | 566.2K +566.2K (+100.0%) | 0.12% +0.119 pp | 0.01% +0.007 pp | USD13.23 +0.0% | 1 qtrs NEW |
| 46 | TWO SIGMA INVESTMENTS, LP | 42.2K -57.5K (-57.7%) | 557.7K -28.4K (-4.8%) | 0.12% -0.160 pp | 0.00% 0.000 pp | USD4.69 +182.1% | 6 qtrs — |
| 47 | RUSSELL INVESTMENTS GROUP, LTD. | 41.3K +36.8K (+812.1%) | 546.5K +519.9K (+1,952.2%) | 0.12% +0.103 pp | 0.00% +0.001 pp | USD12.42 +6.5% | 2 qtrs — |
| 48 | POINT72 ASSET MANAGEMENT, L.P. | 41.2K +41.2K (+100.0%) | 544.8K +544.8K (+100.0%) | 0.11% +0.115 pp | 0.00% +0.001 pp | USD13.23 +0.0% | 1 qtrs NEW |
| 49 | MILITIA CAPITAL PARTNERS, LP | 40.3K +— (+0.0%) | 533.2K +296.2K (+125.0%) | 0.11% +0.000 pp | 0.20% +0.088 pp | USD4.13 +220.3% | 3 qtrs — |
| 50 | TREXQUANT INVESTMENT LP | 39.3K +39.3K (+100.0%) | 520.4K +520.4K (+100.0%) | 0.11% +0.110 pp | 0.00% +0.005 pp | USD13.23 +0.0% | 1 qtrs NEW |
| 51 | BARCLAYS PLC | 37.8K +25.9K (+217.5%) | 499.8K +252.3K (+101.9%) | 0.11% +0.072 pp | 0.00% +0.000 pp | USD11.48 +15.2% | 6 qtrs — |
| 52 | XTX TOPCO LTD | 36.7K +36.7K (+100.0%) | 485.9K +485.9K (+100.0%) | 0.10% +0.102 pp | 0.01% +0.013 pp | USD13.23 +0.0% | 1 qtrs NEW |
| 53 | WOODLINE PARTNERS LP | 31.6K +— (+0.0%) | 417.6K +232.0K (+125.0%) | 0.09% +0.000 pp | 0.00% +0.001 pp | USD20.80 -36.4% | 6 qtrs — |
| 54 | NUVEEN, LLC | 30.8K +— (+0.0%) | 407.4K +226.3K (+125.0%) | 0.09% +0.000 pp | 0.00% +0.000 pp | USD3.76 +251.9% | 4 qtrs — |
| 55 | UBS GROUP AG | 29.9K -7.1K (-19.1%) | 395.3K +178.1K (+82.0%) | 0.08% -0.020 pp | 0.00% +0.000 pp | USD5.59 +136.7% | 5 qtrs — |
| 56 | RHUMBLINE ADVISERS | 29.5K +875.0 (+3.1%) | 390.6K +222.2K (+131.9%) | 0.08% +0.002 pp | 0.00% +0.000 pp | USD4.54 +191.4% | 5 qtrs — |
| 57 | PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | 27.8K +14.0K (+101.9%) | 367.6K +286.7K (+354.4%) | 0.08% +0.039 pp | 0.00% +0.001 pp | USD8.72 +51.7% | 3 qtrs — |
| 58 | WELLS FARGO & COMPANY/MN | 26.6K +6.7K (+33.7%) | 351.9K +234.9K (+200.9%) | 0.07% +0.019 pp | 0.00% +0.000 pp | USD7.12 +85.8% | 5 qtrs — |
| 59 | LOS ANGELES CAPITAL MANAGEMENT LLC | 40.4K -80.5K (-66.6%) | 312.2K -398.9K (-56.1%) | 0.11% -0.225 pp | 0.00% -0.001 pp | USD5.88 +125.0% | 2 qtrs — |
| 60 | STRS OHIO | 22.5K +4.7K (+26.4%) | 297.7K +193.0K (+184.4%) | 0.06% +0.013 pp | 0.00% +0.001 pp | USD5.74 +130.5% | 4 qtrs — |
| 61 | JPMORGAN CHASE & CO | 22.0K -14.8K (-40.2%) | 291.4K +74.8K (+34.5%) | 0.06% -0.041 pp | 0.00% +0.000 pp | USD7.18 +84.3% | 6 qtrs — |
| 62 | TWO SIGMA ADVISERS, LP | 19.5K -68.2K (-77.8%) | 258.0K -257.7K (-50.0%) | 0.05% -0.190 pp | 0.00% -0.001 pp | USD4.63 +185.7% | 3 qtrs — |
| 63 | JANE STREET GROUP, LLC | 18.5K +18.5K (+100.0%) | 244.8K +244.8K (+100.0%) | 0.05% +0.052 pp | 0.00% +0.000 pp | USD13.23 +0.0% | 1 qtrs NEW |
| 64 | RENAISSANCE TECHNOLOGIES LLC | 18.4K -124.6K (-87.1%) | 243.4K -597.4K (-71.0%) | 0.05% -0.348 pp | 0.00% -0.001 pp | USD4.79 +176.2% | 3 qtrs — |
| 65 | FOX RUN MANAGEMENT, L.L.C. | 18.0K +18.0K (+100.0%) | 238.6K +238.6K (+100.0%) | 0.05% +0.050 pp | 0.04% +0.037 pp | USD13.23 +0.0% | 1 qtrs NEW |
| 66 | OCCUDO QUANTITATIVE STRATEGIES LP | 17.7K -1.6K (-8.1%) | 234.6K +121.2K (+106.8%) | 0.05% -0.004 pp | 0.02% +0.002 pp | USD5.88 +125.0% | 2 qtrs — |
| 67 | QUADRATURE CAPITAL LTD | 16.8K +6.0K (+56.2%) | 221.9K +158.7K (+251.5%) | 0.05% +0.017 pp | 0.00% +0.002 pp | USD8.53 +55.1% | 2 qtrs — |
| 68 | GREAT LAKES ADVISORS, LLC | 16.2K +16.2K (+100.0%) | 214.3K +214.3K (+100.0%) | 0.05% +0.045 pp | 0.00% +0.002 pp | USD13.23 +0.0% | 1 qtrs NEW |
| 69 | DEUTSCHE BANK AG\ | 15.8K -9.5K (-37.6%) | 209.0K +60.1K (+40.3%) | 0.04% -0.027 pp | 0.00% +0.000 pp | USD4.02 +229.1% | 4 qtrs — |
| 70 | R SQUARED LTD | 15.0K -11.2K (-42.6%) | 198.5K +44.7K (+29.1%) | 0.04% -0.031 pp | 0.09% +0.027 pp | USD5.88 +125.0% | 2 qtrs — |
| 71 | PRICE T ROWE ASSOCIATES INC /MD/ | 14.8K +2.9K (+24.5%) | 196.0K +126.0K (+180.0%) | 0.04% +0.008 pp | 0.00% +0.000 pp | USD7.33 +80.5% | 2 qtrs — |
| 72 | METLIFE INVESTMENT MANAGEMENT, LLC | 14.4K +14.4K (+100.0%) | 191.0K +191.0K (+100.0%) | 0.04% +0.040 pp | 0.00% +0.001 pp | USD13.23 +0.0% | 1 qtrs NEW |
| 73 | VALOR MANAGEMENT LLC | 13.1K +— (+0.0%) | 173.4K +96.3K (+125.0%) | 0.04% +0.000 pp | 0.31% +0.200 pp | USD20.80 -36.4% | 6 qtrs — |
| 74 | INTECH INVESTMENT MANAGEMENT LLC | 12.2K +363.0 (+3.1%) | 161.3K +91.7K (+131.9%) | 0.03% +0.001 pp | 0.00% +0.001 pp | USD4.40 +200.7% | 3 qtrs — |
| 75 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 11.0K -127.0 (-1.1%) | 145.6K +80.2K (+122.4%) | 0.03% 0.000 pp | 0.00% +0.000 pp | USD4.98 +165.7% | 5 qtrs — |
| 76 | NISA INVESTMENT ADVISORS, LLC | 10.2K +10.0K (+4,219.4%) | 135.4K +134.0K (+9,615.6%) | 0.03% +0.028 pp | 0.00% +0.000 pp | USD13.01 +1.7% | 4 qtrs — |
| 77 | POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY | 6.6K +— (+0.0%) | 87.0K +48.3K (+125.0%) | 0.02% +0.000 pp | 0.00% +0.000 pp | USD4.13 +220.3% | 3 qtrs — |
| 78 | CANADA PENSION PLAN INVESTMENT BOARD | 6.3K +6.3K (+100.0%) | 83.3K +83.3K (+100.0%) | 0.02% +0.018 pp | 0.00% +0.000 pp | USD13.23 +0.0% | 1 qtrs NEW |
| 79 | CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 5.8K +5.8K (+100.0%) | 77.3K +77.3K (+100.0%) | 0.02% +0.016 pp | 0.01% +0.006 pp | USD13.23 +0.0% | 1 qtrs NEW |
| 80 | NEW YORK STATE COMMON RETIREMENT FUND | 5.1K +— (+0.0%) | 67.5K +37.5K (+125.0%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD3.76 +251.9% | 4 qtrs — |
| 81 | CWM, LLC | 3.7K +1.1K (+39.9%) | 49.0K +33.0K (+206.3%) | 0.01% +0.003 pp | 0.00% +0.000 pp | USD6.82 +94.0% | 3 qtrs — |
| 82 | SIMPLEX TRADING, LLC | 2.9K +1.5K (+103.6%) | 37.8K +29.8K (+373.0%) | 0.01% +0.004 pp | 0.00% +0.000 pp | USD8.58 +54.2% | 4 qtrs — |
| 83 | PNC FINANCIAL SERVICES GROUP, INC. | 2.2K -11.0 (-0.5%) | 28.9K +16.0K (+123.9%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD5.61 +135.8% | 3 qtrs — |
| 84 | LEGAL & GENERAL GROUP PLC | 2.2K +— (+0.0%) | 28.5K +15.8K (+125.0%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD5.15 +156.9% | 5 qtrs — |
| 85 | MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 1.7K +1.7K (+100.0%) | 23.0K +23.0K (+100.0%) | 0.00% +0.005 pp | 0.00% +0.000 pp | USD13.23 +0.0% | 1 qtrs NEW |
| 86 | CITIGROUP INC | 1.5K +1.3K (+457.2%) | 20.3K +18.7K (+1,153.7%) | 0.00% +0.004 pp | 0.00% +0.000 pp | USD11.82 +11.9% | 5 qtrs — |
| 87 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 1.5K -21.0 (-1.4%) | 19.3K +10.6K (+121.8%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD5.17 +155.9% | 5 qtrs — |
| 88 | STERLING CAPITAL MANAGEMENT LLC | 1.4K -270.0 (-16.5%) | 18.1K +8.5K (+87.9%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD5.30 +149.6% | 5 qtrs — |
| 89 | AMERITAS INVESTMENT PARTNERS, INC. | 1.3K +— (+0.0%) | 16.8K +9.3K (+125.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.79 +128.5% | 5 qtrs — |
| 90 | TOWER RESEARCH CAPITAL LLC (TRC) | 1.1K -1.5K (-56.7%) | 14.9K -388.0 (-2.5%) | 0.00% -0.004 pp | 0.00% 0.000 pp | USD5.45 +142.8% | 6 qtrs — |
| 91 | ADVISOR GROUP HOLDINGS, INC. | 883.00 -89.0 (-9.2%) | 11.7K +6.3K (+117.9%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD6.27 +111.0% | 6 qtrs — |
| 92 | PARALLEL ADVISORS, LLC | 867.00 +567.0 (+189.0%) | 11.5K +9.7K (+550.2%) | 0.00% +0.002 pp | 0.00% +0.000 pp | USD15.85 -16.5% | 6 qtrs — |
| 93 | AMALGAMATED BANK | 745.00 +331.0 (+80.0%) | 10.0K +8.0K (+400.0%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD9.10 +45.4% | 5 qtrs — |
| 94 | GF FUND MANAGEMENT CO. LTD. | 704.00 +704.0 (+100.0%) | 9.3K +9.3K (+100.0%) | 0.00% +0.002 pp | 0.00% +0.000 pp | USD13.23 +0.0% | 1 qtrs NEW |
| 95 | ROYAL BANK OF CANADA | 640.00 -14.7K (-95.8%) | 9.0K -82.0K (-90.1%) | 0.00% -0.041 pp | 0.00% +0.000 pp | USD5.71 +131.7% | 5 qtrs — |
| 96 | TD WATERHOUSE CANADA INC. | 256.00 +— (+0.0%) | 3.4K +1.9K (+123.3%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD5.79 +128.5% | 5 qtrs — |
| 97 | — | 213.00 +213.0 (+100.0%) | 2.8K +2.8K (+100.0%) | 0.00% +0.001 pp | 0.00% +0.001 pp | USD13.23 +0.0% | 1 qtrs NEW |
| 98 | EVERSOURCE WEALTH ADVISORS, LLC | 145.00 +35.0 (+31.8%) | 1.9K +1.3K (+196.4%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD7.51 +76.2% | 4 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 78 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P Pharmaceuticals ETF XPH | 1.44% | 6.81M | 0.35% |
| 2 | Virtus Biotech Clinical Trials ETF BBC | 0.83% | 478.0K | 0.65% |
| 3 | Invesco Dorsey Wright SmallCap Momentum ETF DWAS | 0.54% | 2.53M | 0.60% |
| 4 | Direxion Daily Pharmaceutical & Medical Bull 3X ETF PILL | 0.30% | 70.0K | 1.22% |
| 5 | iShares Micro-Cap ETF IWC | 0.19% | 2.88M | 0.60% |
| 6 | iShares U.S. Pharmaceuticals ETF IHE | 0.18% | 2.35M | 0.38% |
| 7 | Vanguard U.S. Momentum Factor ETF VFMO | 0.15% | 2.48M | 0.13% |
| 8 | Invesco NASDAQ Biotech UCITS ETF SBIO.L | 0.07% | 344.2K | 0.40% |
| 9 | iShares Nasdaq US Biotechnology UCITS ETF BTEE.L | 0.07% | 54.6K | 0.35% |
| 10 | iShares Nasdaq US Biotechnology UCITS ETF BTEC.L | 0.07% | 815.7K | 0.35% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.75
Neutral
Ratio by volume
0.58
Neutral
Buys
3
Sells
4
Shares acquired
12.4K
Shares disposed
21.2K
Cash buys
—
Cash sales
1.00
Net activity
-8,820
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-23 | GOLDSTEIN DOV A MD | Officer | M-Exempt | D | Stock Option (Right to Buy) | 3,542 | 4.38 | 15.5K | 155,833 | D | ↗ |
| 2026-04-01 | RUBIN PAUL D | Officer | M-Exempt | A | Common Stock | 3,383 | 6.57 | 22.2K | 8,820 | D | ↗ |
| 2026-03-02 | RUBIN PAUL D | Officer | M-Exempt | A | Common Stock | 5,433 | 4.11 | 22.3K | 5,433 | D | ↗ |
| 2026-03-01 | GOLDSTEIN DOV A MD | Officer | M-Exempt | D | Stock Option (Right to Buy) | 3,542 | 4.38 | 15.5K | 159,375 | D | ↗ |
| 2026-02-17 | RUBIN PAUL D | Officer | A-Award | A | Stock Option (Right to Buy) | 110,000 | 19.63 | 2.16M | 110,000 | D | ↗ |
| 2026-02-17 | Morgen Eric | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 110,000 | 19.63 | 2.16M | 110,000 | D | ↗ |
| 2026-02-17 | GOLDSTEIN DOV A MD | Officer | A-Award | A | Stock Option (Right to Buy) | 110,000 | 19.63 | 2.16M | 110,000 | D | ↗ |
| 2026-02-17 | Fortney Kristen | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 330,000 | 19.63 | 6.48M | 330,000 | D | ↗ |
| 2026-02-17 | Barton Shane | Officer | A-Award | A | Stock Option (Right to Buy) | 45,000 | 19.63 | 883.4K | 45,000 | D | ↗ |
| 2026-02-02 | RUBIN PAUL D | Officer | M-Exempt | D | Stock Option (Right to Buy) | 2,000 | 6.57 | 13.1K | 5,383 | D | ↗ |
| 2026-02-01 | GOLDSTEIN DOV A MD | Officer | M-Exempt | D | Stock Option (Right to Buy) | 3,541 | 4.38 | 15.5K | 162,917 | D | ↗ |
| 2026-01-16 | GOLDSTEIN DOV A MD | Officer | M-Exempt | D | Stock Option (Right to Buy) | 3,542 | 4.38 | 15.5K | 166,458 | D | ↗ |
| 2026-01-13 | GOLDSTEIN DOV A MD | Officer | S-Sale | D | Common Stock | 11,663 | 20.54 | 239.5K | 24,331 | D | ↗ |
| 2026-01-13 | Fortney Kristen | Director / Officer | S-Sale | D | Common Stock | 233,107 | 18.12 | 4.22M | 976,949 | D | ↗ |
| 2026-01-02 | RUBIN PAUL D | Officer | M-Exempt | D | Stock Option (Right to Buy) | 5,433 | 4.11 | 22.3K | 16,303 | D | ↗ |
| 2025-12-09 | RUBIN PAUL D | Officer | S-Sale | D | Common Stock | 18,000 | 12.00 | 216.0K | 0 | D | ↗ |
| 2025-12-04 | RUBIN PAUL D | Officer | M-Exempt | D | Stock Option (Right to Buy) | 68,897 | 4.11 | 283.2K | 21,736 | D | ↗ |
| 2025-08-07 | Pande Vijay Satyanand | Director | A-Award | A | Stock Option (Right to Buy) | 22,000 | 4.32 | 95.0K | 22,000 | D | ↗ |
| 2025-06-05 | Hemrajani Rekha | Director | A-Award | A | Stock Option (Right to Buy) | 22,000 | 4.44 | 97.7K | 22,000 | D | ↗ |
| 2025-06-05 | HEALY JAMES | Director | A-Award | A | Stock Option (Right to Buy) | 22,000 | 4.44 | 97.7K | 22,000 | D | ↗ |
| 2025-06-05 | GARNIER JEAN PIERRE | Director | A-Award | A | Stock Option (Right to Buy) | 22,000 | 4.44 | 97.7K | 22,000 | D | ↗ |
| 2025-06-05 | ENRIGHT PATRICK G | Director | A-Award | A | Stock Option (Right to Buy) | 22,000 | 4.44 | 97.7K | 22,000 | D | ↗ |
| 2025-06-05 | Davidson Michael H. | Director | A-Award | A | Stock Option (Right to Buy) | 22,000 | 4.44 | 97.7K | 22,000 | D | ↗ |
| 2025-02-18 | RUBIN PAUL D | Officer | A-Award | A | Stock Option (Right to Buy) | 200,000 | 4.38 | 876.0K | 200,000 | D | ↗ |
| 2025-02-18 | Morgen Eric | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 25,000 | 4.38 | 109.5K | 25,000 | I | ↗ |
| 2025-02-18 | GOLDSTEIN DOV A MD | Officer | A-Award | A | Stock Option (Right to Buy) | 170,000 | 4.38 | 744.6K | 170,000 | D | ↗ |
| 2025-02-18 | Fortney Kristen | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 530,000 | 4.38 | 2.32M | 530,000 | D | ↗ |
| 2025-02-18 | Barton Shane | Officer | A-Award | A | Stock Option (Right to Buy) | 90,000 | 4.38 | 394.2K | 90,000 | D | ↗ |
| 2024-12-18 | Barton Shane | Officer | A-Award | A | Stock Option (Right to Buy) | 40,000 | 4.30 | 172.0K | 40,000 | D | ↗ |
| 2024-09-27 | Hemrajani Rekha | Director | P-Purchase | A | Common Stock | 3,000 | 18.00 | 54.0K | 3,000 | D | ↗ |
| 2024-09-27 | Barton Shane | Officer | P-Purchase | A | Common Stock | 2,632 | 18.00 | 47.4K | 2,632 | D | ↗ |
| 2018-04-02 | Eno Richard P | Director / Officer | A-Award | A | Stock Option (right to buy) | 500,000 | 0.04 | 20.0K | 1,000,000 | — | ↗ |
| 2017-10-02 | Eno Richard P | Director / Officer | A-Award | A | Stock Option (right to buy) | 500,000 | 0.48 | 240.0K | 500,000 | — | ↗ |
| 2017-09-18 | Eno Richard P | Director / Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2017-08-15 | Settino Mario | Officer | P-Purchase | A | Common Stock | 20,000 | 0.75 | 15.0K | 50,000 | — | ↗ |
| 2017-08-15 | RICHSTONE ELLEN B | Director | P-Purchase | A | Common Stock Warrants (right to buy) | 13,333 | 0.75 | 10.0K | 13,333 | — | ↗ |
| 2017-08-15 | Orecchioni Fabrice | Officer | P-Purchase | A | Common Stock | 26,666 | 0.75 | 20.0K | 27,766 | — | ↗ |
| 2017-08-15 | Millis James | Officer | P-Purchase | A | Common Stock Warrants (right to buy) | 13,333 | 0.75 | 10.0K | 13,333 | — | ↗ |
| 2017-08-15 | LAND RAYMOND J | Director | P-Purchase | A | Common Stock Warrants (right to buy) | 40,000 | 0.75 | 30.0K | 40,000 | — | ↗ |
| 2017-08-15 | Haller Heinz | Director | P-Purchase | A | Common Stock Warrants (right to buy) | 40,000 | 0.75 | 30.0K | 40,000 | — | ↗ |
| 2017-08-15 | BRINER KURT W | Director | P-Purchase | A | Common Stock | 133,333 | 0.75 | 100.0K | 285,978 | — | ↗ |
| 2017-08-09 | Settino Mario | Officer | P-Purchase | A | Common Stock | 15,000 | 0.53 | 8.0K | 30,000 | — | ↗ |
| 2017-06-01 | Settino Mario | Officer | A-Award | A | Stock Option (right to buy) | 200,000 | 2.07 | 414.0K | 200,000 | — | ↗ |
| 2017-05-26 | Frost Robert | Director | A-Award | A | Stock-Option (right to buy) | 36,000 | 2.19 | 78.8K | 36,000 | — | ↗ |
| 2017-05-15 | Settino Mario | Officer | — | D | Common Stock | 0 | 0.00 | — | 15,000 | — | ↗ |
| 2017-05-12 | Frost Robert | Director | — | I | Common shares | 0 | 0.00 | — | 14,745 | — | ↗ |
| 2017-05-11 | RICHSTONE ELLEN B | Director | A-Award | A | Stock Option (right to buy) | 36,000 | 2.26 | 81.4K | 36,000 | — | ↗ |
| 2017-05-11 | LAND RAYMOND J | Director | A-Award | A | Stock Option (right to buy) | 36,000 | 2.26 | 81.4K | 36,000 | — | ↗ |
| 2017-05-11 | Haller Heinz | Director | A-Award | A | Stock Option (right to buy) | 36,000 | 2.26 | 81.4K | 36,000 | — | ↗ |
| 2017-05-11 | BRINER KURT W | Director | A-Award | A | Stock Option (right to buy) | 36,000 | 2.26 | 81.4K | 36,000 | — | ↗ |
| 2017-05-01 | Millis James | Officer | A-Award | A | Stock-Option (right to buy) | 25,000 | 2.26 | 56.5K | 25,000 | — | ↗ |
| 2017-02-09 | Saucier Mario | Officer | A-Award | A | Stock-Options (right to buy) | 53,032 | 3.55 | 188.3K | 53,032 | — | ↗ |
| 2017-02-09 | Orecchioni Fabrice | Officer | A-Award | A | Stock-Option (right to buy) | 80,000 | 3.55 | 284.0K | 80,000 | — | ↗ |
| 2017-02-09 | Millis James | Officer | A-Award | A | Stock-Option (right to buy) | 60,686 | 3.55 | 215.4K | 60,686 | — | ↗ |
| 2016-11-09 | Gosbee George Frederick John | Director | P-Purchase | A | Common Stock | 25,000 | 3.87 | 96.6K | 25,000 | — | ↗ |
| 2016-11-08 | BRINER KURT W | Director | P-Purchase | A | Common Stock | 10,000 | 3.84 | 38.4K | 152,645 | — | ↗ |
| 2016-05-24 | BRINER KURT W | Director | P-Purchase | A | Common Stock | 1,000 | 3.69 | 3.7K | 142,645 | — | ↗ |
| 2016-05-23 | BRINER KURT W | Director | P-Purchase | A | Common Stock | 8,915 | 3.70 | 33.0K | 141,645 | — | ↗ |
| 2016-05-20 | BRINER KURT W | Director | P-Purchase | A | Common Stock | 12,100 | 3.54 | 42.8K | 132,730 | — | ↗ |
| 2016-05-19 | RICHSTONE ELLEN B | Director | A-Award | A | Stock Option (right to buy) | 24,000 | 3.35 | 80.4K | 24,000 | — | ↗ |
| 2016-05-19 | LAND RAYMOND J | Director | A-Award | A | Stock-Option (right to buy) | 24,000 | 3.35 | 80.4K | 24,000 | — | ↗ |
| 2016-05-19 | Haller Heinz | Director | A-Award | A | Stock Option (right to buy) | 24,000 | 3.35 | 80.4K | 24,000 | — | ↗ |
| 2016-05-19 | Gosbee George Frederick John | Director | A-Award | A | Stock Option (right to buy) | 24,000 | 3.35 | 80.4K | 24,000 | — | ↗ |
| 2016-05-19 | BRINER KURT W | Director | A-Award | A | Stock Option (right to buy) | 24,000 | 3.35 | 80.4K | 24,000 | — | ↗ |
| 2016-05-11 | Huc Jean-Francois | Director / Officer | P-Purchase | A | Common Stock | 10,000 | 3.22 | 32.2K | 154,222 | — | ↗ |
| 2016-02-22 | Gosbee George Frederick John | Director | A-Award | A | Stock-option (right to buy) | 6,000 | 3.42 | 20.5K | 6,000 | — | ↗ |
| 2016-01-26 | Pettersen Babette | Officer | A-Award | A | Stock Option (right to buy) | 40,000 | 5.00 | 200.0K | 40,000 | — | ↗ |
| 2016-01-26 | Orecchioni Fabrice | Officer | A-Award | A | Stock Option (right to buy) | 100,000 | 5.00 | 500.0K | 100,000 | — | ↗ |
| 2016-01-26 | Millis James | Officer | A-Award | A | Stock Option (right to buy) | 60,000 | 5.00 | 300.0K | 60,000 | — | ↗ |
| 2016-01-26 | Huc Jean-Francois | Director / Officer | A-Award | A | Stock Option (right to buy) | 200,000 | 5.00 | 1.00M | 200,000 | — | ↗ |
| 2016-01-04 | Saucier Mario | Officer | — | D | Stock Option (right to buy) | 200,000 | 5.13 | 1.03M | 0 | — | ↗ |
| 2015-12-03 | Huc Jean-Francois | Director / Officer | X-InTheMoney | A | Common Stock | 154,700 | 1.43 | 221.2K | 171,500 | — | ↗ |
| 2015-08-31 | Ashworth Andrew P. | Officer | P-Purchase | A | Common Stock | 700 | 6.01 | 4.2K | 4,207 | — | ↗ |
| 2015-08-11 | Huc Jean-Francois | Director / Officer | P-Purchase | A | Common Stock | 4,000 | 6.18 | 24.7K | 16,800 | — | ↗ |
| 2015-08-10 | LAND RAYMOND J | Director | P-Purchase | A | Common Stock | 1,500 | 6.71 | 10.1K | 1,500 | — | ↗ |
| 2015-08-07 | Ashworth Andrew P. | Officer | — | D | Common Stock | 0 | 0.00 | — | 3,500 | — | ↗ |
| 2015-08-06 | BRINER KURT W | Director | P-Purchase | A | Common Stock | 40,000 | 5.99 | 239.5K | 120,630 | — | ↗ |
| 2015-05-15 | RICHSTONE ELLEN B | Director | A-Award | A | Stock Option (right to buy) | 10,500 | 9.02 | 94.7K | 10,500 | — | ↗ |
| 2015-05-15 | LINSERT HENRY JR | Director | A-Award | A | Stock Option (right to buy) | 10,500 | 9.02 | 94.7K | 10,500 | — | ↗ |
| 2015-05-15 | LAND RAYMOND J | Director | A-Award | A | Stock Option (right to buy) | 10,500 | 9.02 | 94.7K | 10,500 | — | ↗ |
| 2015-05-15 | Haller Heinz | Director | A-Award | A | Stock Option (right to buy) | 10,500 | 9.02 | 94.7K | 10,500 | — | ↗ |
| 2015-05-15 | BRINER KURT W | Director | A-Award | A | Stock Option (right to buy) | 10,500 | 9.02 | 94.7K | 10,500 | — | ↗ |
| 2015-05-06 | Orecchioni Fabrice | Officer | P-Purchase | A | Common Stock | 1,100 | 9.00 | 9.9K | 1,100 | — | ↗ |
| 2015-05-06 | Millis James | Officer | P-Purchase | A | Common Stock | 1,100 | 9.00 | 9.9K | 1,100 | — | ↗ |
| 2015-05-06 | Laurin Francois | Officer | P-Purchase | A | Common Stock | 2,200 | 9.00 | 19.8K | 12,200 | — | ↗ |
| 2015-05-06 | Huc Jean-Francois | Director / Officer | P-Purchase | A | Common Stock | 8,800 | 9.00 | 79.2K | 12,800 | — | ↗ |
| 2015-05-06 | Haller Heinz | Director | P-Purchase | A | Common Stock | 10,000 | 9.00 | 90.0K | 10,000 | — | ↗ |
| 2015-05-06 | BRINER KURT W | Director | P-Purchase | A | Common Stock | 10,000 | 9.00 | 90.0K | 80,630 | — | ↗ |
| 2015-01-02 | Laurin Francois | Officer | A-Award | A | Stock Option (right to buy) | 200,000 | 8.46 | 1.69M | 200,000 | — | ↗ |
| 2014-12-31 | Laurin Francois | Officer | — | D | Common Stock | 0 | 0.00 | — | 10,000 | — | ↗ |
| 2014-12-31 | Ashworth Andrew P. | Officer | — | D | Stock-Option (right to buy) | 52,083 | 6.98 | 363.5K | 0 | — | ↗ |
| 2014-12-05 | Pettersen Babette | Officer | A-Award | A | Stock Option (right to buy) | 40,000 | 10.16 | 406.4K | 40,000 | — | ↗ |
| 2014-12-05 | Orecchioni Fabrice | Officer | A-Award | A | Stock Option (right to buy) | 60,000 | 10.16 | 609.6K | 60,000 | — | ↗ |
| 2014-12-05 | Millis James | Officer | A-Award | A | Stock Option (right to buy) | 50,000 | 10.16 | 508.0K | 50,000 | — | ↗ |
| 2014-12-05 | Huc Jean-Francois | Director / Officer | A-Award | A | Stock Option (right to buy) | 200,000 | 10.16 | 2.03M | 200,000 | — | ↗ |
| 2014-11-10 | BRINER KURT W | Director | P-Purchase | A | Common Stock | 3,100 | 9.30 | 28.8K | 61,633 | — | ↗ |
| 2014-09-09 | BRINER KURT W | Director | P-Purchase | A | Common Stock | 5,000 | 12.00 | 60.0K | 55,630 | — | ↗ |
| 2014-08-25 | BRINER KURT W | Director | P-Purchase | A | Common Stock | 14,150 | 11.50 | 162.7K | 50,630 | — | ↗ |
| 2014-08-22 | BRINER KURT W | Director | P-Purchase | A | Common Stock | 100 | 11.50 | 1.2K | 36,480 | — | ↗ |
| 2014-08-12 | BRINER KURT W | Director | P-Purchase | A | Common Stock | 200 | 11.50 | 2.3K | 36,380 | — | ↗ |
| 2014-08-11 | BRINER KURT W | Director | P-Purchase | A | Common Stock | 2,180 | 11.50 | 25.1K | 36,180 | — | ↗ |
| 2014-07-16 | Huc Jean-Francois | Director / Officer | P-Purchase | A | Common Stock | 4,000 | 12.00 | 48.0K | 4,000 | — | ↗ |
| 2014-05-27 | RICHSTONE ELLEN B | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2014-05-27 | Lucquin Denis | Director | A-Award | A | Stock Option (right to buy) | 10,500 | 10.00 | 105.0K | 10,500 | — | ↗ |
| 2014-05-27 | LINSERT HENRY JR | Director | A-Award | A | Stock Option (right to buy) | 10,500 | 10.00 | 105.0K | 10,500 | — | ↗ |
| 2014-05-27 | LAND RAYMOND J | Director | A-Award | A | Stock Option (right to buy) | 10,500 | 10.00 | 105.0K | 10,500 | — | ↗ |
| 2014-05-27 | Haller Heinz | Director | A-Award | A | Stock Option (right to buy) | 10,500 | 10.00 | 105.0K | 10,500 | — | ↗ |
| 2014-05-27 | BRINER KURT W | Director | A-Award | A | Stock Option (right to buy) | 10,500 | 10.00 | 105.0K | 10,500 | — | ↗ |
| 2014-05-12 | Huc Jean-Francois | Director / Officer | P-Purchase | A | Common Stock | 3,000 | 10.17 | 30.5K | 20,345 | — | ↗ |
| 2014-05-12 | Ashworth Andrew P. | Officer | P-Purchase | A | Common Stock | 3,000 | 10.00 | 30.0K | 3,000 | — | ↗ |
| 2014-01-02 | Orecchioni Fabrice | Director / Officer | — | D | Stock Option (right to buy) | 135,000 | 6.98 | 942.3K | 0 | — | ↗ |
| 2013-11-14 | BRINER KURT W | Director | P-Purchase | A | Common Stock | 7,200 | 6.95 | 50.0K | 33,200 | — | ↗ |
| 2013-11-11 | Pettersen Babette | Officer | A-Award | A | Stock Option (right to buy) | 100,000 | 6.98 | 698.0K | 100,000 | — | ↗ |
| 2013-11-11 | Millis James | Officer | A-Award | A | Stock Option (right to buy) | 80,000 | 6.98 | 558.4K | 80,000 | — | ↗ |
| 2013-11-11 | Lucquin Denis | Director | A-Award | A | Stock Option (right to buy) | 6,125 | 6.98 | 42.8K | 6,125 | — | ↗ |
| 2013-11-11 | LAND RAYMOND J | Director | A-Award | A | Stock Option (right to buy) | 6,125 | 6.98 | 42.8K | 6,125 | — | ↗ |
| 2013-11-11 | Huc Jean-Francois | Director / Officer | A-Award | A | Stock Option (right to buy) | 450,000 | 6.98 | 3.14M | 450,000 | — | ↗ |
| 2013-11-11 | Haller Heinz | Director | A-Award | A | Stock Option (right to buy) | 6,125 | 6.98 | 42.8K | 6,125 | — | ↗ |
| 2013-11-11 | CAMP WILLIAM H | Director | A-Award | A | Stock Option (right to buy) | 6,125 | 6.98 | 42.8K | 6,125 | — | ↗ |
| 2013-11-11 | BRINER KURT W | Director | A-Award | A | Stock Option (right to buy) | 6,125 | 6.98 | 42.8K | 6,125 | — | ↗ |
| 2013-11-11 | Ashworth Andrew P. | Officer | A-Award | A | Stock Option (right to buy) | 100,000 | 6.98 | 698.0K | 100,000 | — | ↗ |
| 2013-08-29 | Huc Jean-Francois | Director / Officer | P-Purchase | A | Common Stock | 5,000 | 4.25 | 21.3K | 17,345 | — | ↗ |
| 2013-08-15 | BRINER KURT W | Director | P-Purchase | A | Common Stock | 13,000 | 5.49 | 71.4K | 26,000 | — | ↗ |
| 2013-06-26 | LAND RAYMOND J | Director | A-Award | A | Stock Option (right to buy) | 17,500 | 10.55 | 184.6K | 17,500 | — | ↗ |
| 2011-09-12 | Ashworth Andrew P. | Officer | — | D | Stock Option (right to buy) | 56,000 | 10.55 | 590.6K | 0 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-13.1K
Shares Outstanding
35.98M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Kristen Fortney Chief Executive Officer and President | 600.0K | — | — | 1.94M | 330.0K | 15.2K | 2.89M | 67.26% | ↗ |
| 2 | 2025 | Paul Rubin Chief Medical Officer | 520.2K | — | — | 732.6K | 208.1K | 15.2K | 1.48M | 49.63% | ↗ |
| 3 | 2025 | Eric Morgen Chief Operating Officer | 499.6K | — | — | 732.6K | 199.8K | 15.2K | 1.45M | 50.62% | ↗ |
| 4 | 2024 | Kristen Fortney, Ph.D. Chief Executive Officer and President | 521.0K | — | — | 11.48M | 208.4K | 15.0K | 12.23M | 93.91% | ↗ |
| 5 | 2024 | Eric Morgen, M.D. Chief Operating Officer | 457.7K | — | — | 1.83M | 160.2K | 15.0K | 2.47M | 74.33% | ↗ |
| 6 | 2024 | Paul Rubin, M.D. Chief Medical Officer | 488.1K | — | — | 1.25M | 170.8K | 15.0K | 1.92M | 64.97% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Kristen Fortney | Co-Founder, Chief Executive Officer, President, Treasurer, Secretary & Director | 945.2K | — |
| Paul D. Rubin | Chief Medical Officer & Executive Vice President of Research | 743.5K | — |
| Eric Morgen | Co-Founder, Chief Operating Officer & Director | 714.6K | male |
| Julie Gammelgard | Senior Vice President of People | — | female |
| Naisha Shah | SVP of Data Science | — | female |
| Patrick Martin | Senior Vice President of Clinical Science | — | male |
| Peng Leong | Chief Business Officer & Therapeutic Area Head of Brain Aging | — | — |
| Rusty Montgomery | Senior Vice President of Research | — | male |
| Shane Barton | Senior Vice President of Finance & Accounting | — | male |
| Sullivan | Chief Strategy Officer | — | male |
| Ann C. Neale | Chief Development Officer | — | female |
| Yan Wang | Senior Vice President of Translational Aging Biology | — | female |
ESG Rating
ESG Score History DRUG MANUFACTURERS - SPECIALTY & GENERIC
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for BIOA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
